NCT02014285

Brief Summary

Examination of serial muscle ultrasounds and muscle sampling within the population of ICU patients who require mechanical ventilation for acute respiratory failure, will lead to the ability of investigators to link specific baseline comorbidities, drugs, or fluid administrations, to the onset and duration of architectural changes within muscle and correlate ultimately with muscle function. With this study, we will be better able to understand the relationships between the pattern of resolution of the muscle architectural abnormalities within the context of multiple other clinical abnormalities and therapies present and rendered to ICU patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

November 27, 2013

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 18, 2013

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2017

Completed
Last Updated

November 8, 2017

Status Verified

August 1, 2017

Enrollment Period

4.5 years

First QC Date

November 27, 2013

Last Update Submit

November 6, 2017

Conditions

Keywords

Acute Respiratory FailureCritical IllnessMechanical VentilationMuscle ArchitectureMuscle Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Days of Hospitalization

    The ultrasound data analysis may allow for a correlation to be drawn between a pattern of ultrasound changes and length of stay.

    2 months

Study Arms (1)

Muscle Ultrasound/Sample

30 subjects enrolled from Wake Forest Baptist Health Intensive Care Units. Each study subject will undergo an ultrasound to examine the size and echogenicity of their muscles and a muscle biopsy from the rectus femoris. The muscles studied will include the biceps brachii, wrist extensors, quadriceps, and tibialis anterior.

Procedure: Muscle Ultrasound and Muscle Sample

Interventions

The muscles to undergo ultrasound will include the biceps brachii, wrist extensors, quadriceps, and tibialis anterior. A muscle sample will be taken from the rectus femoris.

Muscle Ultrasound/Sample

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants will consist of 30 patients with Acute Respiratory Failure admitted to the Intensive Care Units of Wake Forest Baptist Health.

You may qualify if:

  • Age \> 18 years
  • Mechanically ventilated via an endotracheal tube or mask
  • New diagnosis of Acute Lung Injury or Sepsis

You may not qualify if:

  • Upon Principle Investigator discretion, patient not suitable for study
  • Moribund
  • Other Research Study without co-enrollment permissions
  • Pregnancy
  • Primary neuropathies
  • Amputees
  • Preadmission immunocompromised state (HIV, \>20mg prednisone/day, other immunosuppressive therapy)
  • BMI \>45 (difficulty obtaining biopsy)
  • Underlying neuromuscular disease
  • Acute stroke
  • Hip fracture, unstable C spine, or pathological fracture
  • Current hospitalization or transferring hospital stay \>80 hours
  • CPR previous to consent without signs of full neurologic recovery
  • Previous hospitalization within past 30 days
  • Cognitive impairment prior to ICU illness
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Muscle tissue and serum/plasm

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Clark Files, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR
  • Peter E Morris, MD

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2013

First Posted

December 18, 2013

Study Start

November 1, 2012

Primary Completion

May 3, 2017

Study Completion

May 3, 2017

Last Updated

November 8, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations